Stem cells in the brain have enabled many lab discoveries and soon will be tested in children with a rare disease, but it could be years or decades before possible treatments for brain disorders are available, experts say.
One of the main reasons for the slow progress: the science is so complex, controversial and expensive, big drug companies are staying far away, said Alan Colman, chief executive officer of ES Cell International in Singapore and a creator of the cloned sheep Dolly nearly a decade ago.
Office of Strategic Communication